Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Tulare › NPI 1801366711
Hospital

Adventist Health Tulare

Adventist Health Tulare was paid $17.13M by Medicaid between Feb 2019 and Dec 2024, across 234 billing codes. Its largest line is 0450, Emergency room services — 46% of everything it billed.

33Billing provider infoADVENTIST HEALTH TULARE
TULARE, CA 93274
33aNPI1801366711assigned 12/04/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.13M
24GClaims632,462
24DCodes billed234
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#135 of 410
Median peer was paid$6.90M
This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201968,816$1.83M
202075,630$1.90M
202191,988$2.56M
202296,391$3.35M
2023155,331$3.79M
2024incomplete144,306$3.69M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 46% 61,726 54,112 $7.81M
99199 Unlisted special service, procedure or report 7.6% 24,676 21,102 $1.31M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 4,753 4,494 $511K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2.7% 13,449 12,446 $469K
70450 Computed tomography, head or brain; without contrast material 2.5% 5,310 5,012 $425K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.2% 4,811 4,697 $375K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.9% 7,349 7,062 $331K
80053 Comprehensive metabolic panel 1.5% 30,172 27,462 $265K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 7,610 7,019 $251K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.4% 7,358 7,067 $246K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.3% 4,358 4,248 $220K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 2,874 2,712 $208K
222 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 13,863 $196K
71046 Radiologic examination, chest; 2 views 1.1% 16,214 $190K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 34,946 $188K
96361 Intravenous infusion, hydration; each additional hour 1.1% 6,426 $187K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.0% 5,391 $175K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,189 $149K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,139 $131K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,774 $130K
96375 Therapeutic injection; each additional sequential IV push <1% 5,905 $124K
0360 <1% 750 $119K
80306 <1% 9,752 $117K
J3490 Unclassified drugs <1% 24,806 $105K
99070 <1% 14,836 $102K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,815 $97K
71045 Radiologic examination, chest; single view <1% 12,284 $95K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,714 $85K
99283 Emergency room visit (moderate) <1% 1,285 $79K
81001 <1% 26,347 $78K
Z7502 <1% 2,715 $76K
72125 Computed tomography, cervical spine; without contrast material <1% 757 $75K
84484 <1% 11,299 $74K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,195 $71K
0270 <1% 27,861 $70K
71275 Computed tomographic angiography, chest, with contrast material <1% 621 $62K
83880 <1% 3,745 $59K
83690 <1% 12,874 $59K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 8,241 $59K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,412 $57K
99284 Emergency room visit (serious) <1% 1,057 $57K
76801 <1% 1,710 $49K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,666 $48K
76830 Ultrasound, transvaginal <1% 1,301 $45K
83605 <1% 6,133 $44K
81025 <1% 10,374 $41K
93971 <1% 722 $39K
99285 Emergency room visit (most serious) <1% 781 $39K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,631 $38K
0402 <1% 400 $37K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,340 $34K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,626 $31K
73130 <1% 1,651 $31K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 607 $28K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 293 $28K
73610 <1% 1,491 $28K
73630 <1% 1,631 $27K
0710 <1% 1,166 $27K
Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml <1% 2,908 $26K
90715 <1% 1,184 $25K
87040 <1% 2,935 $24K
J7030 Infusion, normal saline solution , 1000 cc <1% 5,917 $24K
0250 <1% 4,720 $23K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,886 $23K
73562 <1% 1,341 $23K
80048 Basic metabolic panel (calcium, ionized) <1% 3,565 $22K
73030 <1% 1,237 $22K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 3,871 $22K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 4,309 $21K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 601 $20K
84443 Thyroid stimulating hormone (TSH) <1% 1,967 $19K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,967 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,431 $19K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,179 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,617 $18K
76770 <1% 487 $18K
70486 <1% 231 $18K
82805 <1% 971 $18K
74018 <1% 1,461 $17K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 525 $16K
84702 <1% 2,589 $16K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,044 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 750 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,256 $14K
J2704 Injection, propofol, 10 mg <1% 1,681 $14K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 736 $14K
73110 <1% 811 $14K
0300 <1% 1,625 $13K
77067 Screening mammography, bilateral, including computer-aided detection <1% 544 $12K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,646 $12K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 60 $11K
83735 <1% 2,419 $11K
59025 Fetal non-stress test <1% 967 $11K
0320 <1% 470 $11K
74019 <1% 608 $11K
93970 <1% 130 $9K
76857 <1% 482 $9K
85610 <1% 3,616 $9K
76641 <1% 340 $9K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,450 $9K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 134 $9K
72100 <1% 499 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 803 $8K
85379 <1% 982 $7K
86901 <1% 2,773 $7K
73090 <1% 375 $7K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 667 $7K
0351 <1% 109 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 257 $7K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 142 $7K
0760 <1% 230 $7K
86900 <1% 2,764 $7K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 57 $6K
Z7610 <1% 623 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,282 $6K
J1170 Injection, hydromorphone, up to 4 mg <1% 972 $6K
76000 <1% 426 $6K
86140 <1% 1,389 $6K
0301 <1% 1,706 $6K
29125 <1% 156 $6K
47562 <1% 38 $5K
84703 <1% 2,051 $5K
0352 <1% 181 $5K
76536 <1% 195 $5K
76870 <1% 187 $5K
12001 <1% 89 $5K
86850 <1% 878 $5K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,312 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,259 $5K
94760 <1% 941 $5K
0720 <1% 43 $5K
73590 <1% 318 $4K
85730 <1% 1,293 $4K
0403 <1% 26 $4K
73502 <1% 153 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 347 $4K
94664 <1% 1,018 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 831 $4K
73221 <1% 40 $4K
73080 <1% 254 $4K
80179 <1% 496 $4K
82962 <1% 1,537 $4K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 2,932 $4K
0259 <1% 814 $4K
26145 <1% 36 $3K
87420 <1% 337 $3K
80143 <1% 299 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,170 $3K
70551 Magnetic resonance imaging, brain; without contrast material <1% 25 $3K
87081 <1% 465 $3K
72040 <1% 158 $2K
96376 <1% 652 $2K
82077 <1% 570 $2K
82550 <1% 558 $2K
84145 <1% 284 $2K
0305 <1% 803 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 604 $2K
72131 <1% 29 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 361 $2K
84439 <1% 462 $2K
87186 <1% 1,138 $2K
73564 <1% 142 $2K
64721 <1% 39 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 15 $2K
80061 Lipid panel <1% 442 $2K
87070 <1% 220 $2K
80305 <1% 126 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 283 $2K
0324 <1% 330 $2K
0307 <1% 828 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 176 $2K
71250 <1% 28 $2K
J2060 Injection, lorazepam, 2 mg <1% 455 $1K
36415 Collection of venous blood by venipuncture <1% 1,810 $1K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 16 $1K
87077 <1% 1,154 $1K
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 132 $1K
0306 <1% 278 $1K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 131 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 415 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 80 $1K
12002 <1% 26 $1K
29515 <1% 36 $1K
72070 <1% 45 $1K
84100 <1% 479 $986.17
12011 <1% 20 $890.03
0302 <1% 199 $783.71
82248 <1% 256 $741.22
82553 <1% 92 $676.02
85651 <1% 248 $640.18
85652 <1% 367 $604.34
77066 Tomosynthesis, mammo <1% 13 $545.56
J2550 Injection, promethazine hcl, up to 50 mg <1% 98 $467.61
88304 <1% 18 $447.94
J1171 Injection, hydromorphone, 0.1 mg <1% 21 $444.53
J0780 Injection, prochlorperazine, up to 10 mg <1% 94 $429.51
87205 <1% 117 $393.88
86920 <1% 14 $391.55
73140 <1% 26 $369.40
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 65 $367.91
80076 <1% 82 $354.53
0730 <1% 12 $345.60
J1815 Injection, insulin, per 5 units <1% 101 $332.14
82140 <1% 53 $321.74
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 27 $311.67
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 54 $311.06
84481 <1% 27 $286.85
86780 <1% 39 $269.44
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 25 $265.19
87210 <1% 86 $258.75
87220 <1% 81 $256.47
82803 <1% 16 $232.71
86703 <1% 26 $212.39
94644 <1% 25 $177.68
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 313 $167.00
0410 <1% 15 $166.24
J1953 Injection, levetiracetam, 10 mg <1% 29 $154.95
73552 <1% 13 $143.29
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 12 $136.48
93356 <1% 16 $117.41
87899 <1% 14 $102.24
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 200 $96.46
J3370 Injection, vancomycin hcl, 500 mg <1% 14 $91.68
84436 <1% 12 $85.87
J0736 Injection, clindamycin phosphate, 300 mg <1% 13 $84.30
72170 <1% 14 $82.47
83540 <1% 29 $62.50
J3475 Injection, magnesium sulfate, per 500 mg <1% 26 $50.33
J1630 Injection, haloperidol, up to 5 mg <1% 173 $43.40
86592 <1% 16 $37.71
0771 <1% 15 $25.67
J8540 Dexamethasone, oral, 0.25 mg <1% 237 $2.41
A4649 Surgical supply; miscellaneous 0% 53 $0.00
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTHORDARSON, HEIDAR (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under THORDARSON, HEIDAR

Full network →
ProviderLocationPaid
Hanford Community HospitalHanford, CA$37.77M
Reedley Community HospitalReedley, CA$15.46M
Castle Medical CenterKailua, HI$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.